Guangdong hybribio biotech announced that the company plans to use its own funds and special bank repurchase loan funds to buy back some of its shares through centralized bidding trade. The type of shares to be repurchased is the company’s issued ordinary shares (A shares) in RMB, and the purpose of the repurchase is to maintain the company's value and shareholder rights. The repurchase price will not exceed RMB 9.00 per share (inclusive), and the total repurchase funds will be no less than RMB 50 million (inclusive) and no more than RMB 100 million (inclusive). The implementation period for the repurchase of shares is no more than 3 months from the date when the company's board of directors approves this share repurchase plan.